Share of Cost, Huge Cancer Knowledge Resource Made Public
Friday, Aug. 31st 2012 7:17 AM
Bringing the goal of personalized medicine a step closer, scientists who design anti-cancer treatments and clinical trials now have access to a huge cancer knowledge resource, thanks to a collaboration between industry and academia. A report in the 28 March online issue of Nature describes how the Cancer Cell Line Encyclopedia (CCLE) brings together genome data and predictors of drug response for 947 cancer cell lines. The ultimate cancer treatment is one that matches the right drug to the right target in the right patient. This is the goal of personalized medicine.
Related posts:
- Leftover Embryonic Cells Connect Gastric Reflux And Cancer The ultimate source of some cancers is embryonic cells. Research published in the June 24th Cell, a Cell Press publication, traces the precursor of deadly esophageal cancers to leftover embryonic cells found in all adults. Some people with gastric reflux disease have a greater risk of developing esophageal cancer....
- California Share of Cost, Food Dye Ban Implemented Or Considered By Some Health Authorities After Cancer And Hyperactivity Link Found California Share of Cost, Food Dye Ban Implemented Or Considered By Some Health Authorities After Cancer And Hyperactivity Link Found: After new scientific evidence revealed a possible link between food dyes and childhood cancer and hyperactivity, Australian food authorities are reported to be considering banning food colorings from breakfast cereals and confectionary items. The research […]...
- Researchers Find More Evidence That Malaria Drug Could Help Combat Cancer, And That Breaks From Treatment Could Improve Results Scientists investigating the cancer-fighting properties of artesunate a drug commonly used to treat malaria have found early evidence that combining it with an existing cancer drug has the potential to make each drug more effective than when used alone. They also found that regular treatment breaks could improve success levels. The findings, recently published in […]...
- Share of Cost, Esophageal Cancer Risk Lower Than Expected For GERD Patients Share of Cost, The risk of esophageal cancer among patients who suffer from gastroesophageal reflux disease (GERD) is not as high as many may think, according to new research from University of Michigan gastroenterologists. GERD is considered a relative risk for developing esophageal adenocarcinoma, but the absolute risk is not known, says Joel Rubenstein, M.D., […]...
- Share of Cost, For Acid Reflux Disease Patients, Esophageal Cancer Risk Lower Than Expected Share of Cost, The risk of esophageal cancer among patients who suffer from gastroesophageal reflux disease (GERD) is not as high as many may think, according to new research from University of Michigan gastroenterologists. GERD is considered a relative risk for developing esophageal adenocarcinoma, but the absolute risk is not known, says Joel Rubenstein, M.D., […]...
- Share of Cost, Study Shows Promise For New Drug To Treat Fragile X The first drug to treat the underlying disorder instead of the symptoms of Fragile X, the most common cause of inherited intellectual disability, shows some promise according to a new study published in the January issue of Science Translational Medicine. Researchers from Rush University Medical Center helped design the study and are now participating in […]...
- Homing In On Genetic Signature Of Esophageal Cancer University of Rochester Medical Center researchers have pinpointed two genes that are amplified in the worst cases of esophageal cancer, providing data to support a new investigational treatment that targets those same genes. The study, led by Tony Godfrey, Ph.D., a research associate professor of Surgery at the James P....
- Share of Cost, Einstein Receives $4 Million To Test HPV Microbicide Share of Cost, Einstein Receives $4 Million To Test HPV Microbicide — The National Cancer Institute has awarded Albert Einstein College of Medicine of Yeshiva University $4.1 million to test the microbicide Carraguard® against the human papillomavirus (HPV), which causes cervical cancer. The research will evaluate the efficacy of Carraguard®, a clear gel made from […]...
- Share of Cost: Stiff Sediments Made 2004 Sumatra Earthquake Deadliest In History An international team of geoscientists has discovered an unusual geological formation that helps explain how an undersea earthquake off the coast of Sumatra in December 2004 spawned the deadliest tsunami in recorded history....
- Share of Cost, Federal Digest Washington Post FDA considers revoking approval of Avastin for advanced breast cancer – Rob Stein reports on agency’s decision after follow up studies on high-cost drug that won fast-track approval show little if any benefit and potentially dangerous side-effects; cancer activists split on decision, which some see as harbinger of cost consideration under new health […]...
- When Budgets Are Tight, There Are Better Options Than Colonoscopies For Colorectal Cancer Screening [Web First] A critical challenge facing cancer screening programs, particularly those aimed at uninsured people with low incomes, is choosing the screening test that makes the most efficient use of limited budgets. For colorectal cancer screening, there is growing momentum to use colonoscopy, which is an expensive test. In this study, we modeled scenarios to assess whether […]...
- Texas Share of Cost, Axanum And Expanded Nexium Indication Rejected By FDA Texas Share of Cost, Axanum And Expanded Nexium Indication Rejected By FDA: The Food and Drug Administration (FDA), USA has denied approval of AstraZeneca’s Axanum (aspirin plus esomeprazole magnesium) and an expanded indication for AstraZeneca’s Nexium (esomeprazole magnesium). AstraZeneca received a CRL (Complete Response Letter) for the new drug application for Axanum tablets, as well […]...
- Asthma And Eczema Sufferers Have A Lower Risk Of Developing A Cancer Men who had a history of asthma or eczema generally had a lower risk of developing cancer, according to a study carried out by researchers at INRS Institut Armand-Frappier, the Research Centre of the Centre hospitalier de l’Université de Montréal, and McGill University…...
- Share of Cost, Medi-Cal, Also In Global Health News: HIV In Cities; NIH Director’s Role In Global Health; Access To Healthcare In Kenya; Food Aid In Ethiopia; More UNAIDS Calls On Cities To Enhance Response To HIV; China Vows To Step Up Prevention UNAIDS has “issued a call for cities to ‘take the lead in making HIV history’ by enhancing their response to the epidemic,” UN News Centre reports....
- Share of Cost, Two Talks With Teens Leads To Less Marijuana Use For At Least A Year Marijuana is the most prevalent illicit drug used by teenagers and adults around the world. Nearly a third of high school students in the United States report smoking it, and most high schoolers say they have access to the drug. To many people, smoking pot is no big deal. They cite reasons such as: “it […]...
Posted on Friday, Aug. 31st 2012 7:17 AM | by Share of Cost | in Share of Cost | No Comments »